Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Operating Expenses: 2020-2024

Historic Operating Expenses for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Dec 2024 value amounting to $324.9 million.

  • Arcutis Biotherapeutics' Operating Expenses rose 8.20% to $90.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $356.2 million, marking a year-over-year increase of 11.08%. This contributed to the annual value of $324.9 million for FY2024, which is 8.06% up from last year.
  • Arcutis Biotherapeutics' Operating Expenses amounted to $324.9 million in FY2024, which was up 8.06% from $300.7 million recorded in FY2023.
  • Arcutis Biotherapeutics' Operating Expenses' 5-year high stood at $324.9 million during FY2024, with a 5-year trough of $136.6 million in FY2020.
  • In the last 3 years, Arcutis Biotherapeutics' Operating Expenses had a median value of $305.3 million in 2022 and averaged $310.3 million.
  • In the last 5 years, Arcutis Biotherapeutics' Operating Expenses spiked by 51.14% in 2021 and then declined by 1.51% in 2023.
  • Arcutis Biotherapeutics' Operating Expenses (Yearly) stood at $136.6 million in 2020, then skyrocketed by 51.14% to $206.5 million in 2021, then soared by 47.83% to $305.3 million in 2022, then declined by 1.51% to $300.7 million in 2023, then grew by 8.06% to $324.9 million in 2024.